Literature DB >> 29626695

Multi-functional electrospun antibacterial core-shell nanofibrous membranes for prolonged prevention of post-surgical tendon adhesion and inflammation.

K T Shalumon1, Chialin Sheu1, Chih-Hao Chen2, Shih-Heng Chen2, Gils Jose1, Chang-Yi Kuo1, Jyh-Ping Chen3.   

Abstract

The possibility of endowing an electrospun anti-adhesive barrier membrane with multi-functionality, such as lubrication, prevention of fibroblast attachment and anti-infection and anti-inflammation properties, is highly desirable for the management of post-surgical tendon adhesion. To this end, we fabricated core-shell nanofibrous membranes (CSNMs) with embedded silver nanoparticles (Ag NPs) in the poly(ethylene glycol) (PEG)/poly(caprolactone) (PCL) shell and hyaluronic acid (HA)/ibuprofen in the core. HA imparted a lubrication effect for smooth tendon gliding and reduced fibroblast attachment, while Ag NPs and ibuprofen functioned as anti-infection and anti-inflammation agents, respectively. CSNMs with a PEG/PCL/Ag shell (PPA) and HA core containing 0% (H/PPA), 10% (HI10/PPA), 30% (HI30/PPA) and 50% (HI50/PPA) ibuprofen were fabricated through co-axial electrospinning and assessed through microscopic, spectroscopic, thermal, mechanical and drug release analyses. Considering nutrient passage through the barrier, the microporous CSNMs exerted the same barrier effect but drastically increased the mass transfer coefficients of bovine serum albumin compared with the commercial anti-adhesive membrane SurgiWrap®. Cell attachment/focal adhesion formation of fibroblasts revealed effective reduction of initial cell attachment on the CSNM surface with minimum cytotoxicity (except HI50/PPA). The anti-bacterial effect against both Gram-negative and Gram-positive bacteria was verified to be due to the Ag NPs in the membranes. In vivo studies using H/PPA and HI30/PPA CSNMs and SurgiWrap® in a rabbit flexor tendon rupture model demonstrated the improved efficacy of HI30/PPA CSNMs in reducing inflammation and tendon adhesion formation based on gross observation, histological analysis and functional assays. We conclude that HI30/PPA CSNMs can act as a multifunctional barrier membrane to prevent peritendinous adhesion after tendon surgery. STATEMENT OF SIGNIFICANCE: A multi-functional anti-adhesion barrier membrane that could reduce fibroblasts attachment and penetration while simultaneously prevent post-surgical infection and inflammation is urgently needed. To this end, we prepared electrospun core-shell hyaluronic acid + ibuprofen/polyethylene glycol + polycaprolactone + Ag nanoparticles nanofibrous membranes by co-axial electrospinning as an ideal anti-adhesive membrane. The core-shell structure could meet the need of a desirable anti-adhesion barrier through release of ibuprofen and Ag nanoparticles to reduce infection and inflammation while hyaluronic acid can reduce fibroblasts adhesion. The superior performance of this multi-functional core-shell nanofibrous membrane in preventing peritendinous adhesion and post-surgical inflammation was demonstrated in a rabbit flexor tendon rupture model.
Copyright © 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-adhesion; Core-shell nanofibers; Electrospinning; Hyaluronic acid; Ibuprofen; Silver nanoparticle; Tendon adhesion

Mesh:

Substances:

Year:  2018        PMID: 29626695     DOI: 10.1016/j.actbio.2018.03.044

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  22 in total

1.  Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications.

Authors:  Jiajia Xue; Tong Wu; Yunqian Dai; Younan Xia
Journal:  Chem Rev       Date:  2019-03-27       Impact factor: 60.622

2.  MicroRNA-21-3p Engineered Umbilical Cord Stem Cell-Derived Exosomes Inhibit Tendon Adhesion.

Authors:  Zhixiao Yao; Juehong Li; Xu Wang; Shiqiao Peng; Jiexin Ning; Yun Qian; Cunyi Fan
Journal:  J Inflamm Res       Date:  2020-07-07

3.  Electrospun thymosin Beta-4 loaded PLGA/PLA nanofiber/ microfiber hybrid yarns for tendon tissue engineering application.

Authors:  Shaohua Wu; Rong Zhou; Fang Zhou; Philipp N Streubel; Shaojuan Chen; Bin Duan
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2019-10-12       Impact factor: 7.328

Review 4.  [Application of medical biomaterials in prevention and treatment of tendon adhesion].

Authors:  Mingmin Zhang; Gaohong Ren
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-08-15

5.  An Integrative Dual-Layer Poly-L-Lactic Acid Fibrous Membrane Prevents Peritendinous Adhesions.

Authors:  Wei Wang; Ning He; Zhixiao Yao; Xu Wang; Hui Wang; Miao He; Yusheng Li; Yun Qian
Journal:  Front Bioeng Biotechnol       Date:  2020-05-05

6.  Hydration-Enhanced Lubricating Electrospun Nanofibrous Membranes Prevent Tissue Adhesion.

Authors:  Liang Cheng; Yi Wang; Guoming Sun; Shizhu Wen; Lianfu Deng; Hongyu Zhang; Wenguo Cui
Journal:  Research (Wash D C)       Date:  2020-03-19

7.  Ibuprofen-Loaded Hyaluronic Acid Nanofibrous Membranes for Prevention of Postoperative Tendon Adhesion through Reduction of Inflammation.

Authors:  Chien-Tzung Chen; Chih-Hao Chen; Chialin Sheu; Jyh-Ping Chen
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

8.  Surface modification of electrospun fibers with mechano-growth factor for mitigating the foreign-body reaction.

Authors:  Yang Song; Linhao Li; Weikang Zhao; Yuna Qian; Lili Dong; Yunnan Fang; Li Yang; Yubo Fan
Journal:  Bioact Mater       Date:  2021-03-01

9.  Improved tendon healing by a combination of Tanshinone IIA and miR-29b inhibitor treatment through preventing tendon adhesion and enhancing tendon strength.

Authors:  Haiying Zhou; Shuai Jiang; Pengfei Li; Hui Shen; Hu Yang; Shengquan Xu; Chenyi Ye; Mingjian Chen; Hui Lu
Journal:  Int J Med Sci       Date:  2020-04-27       Impact factor: 3.738

Review 10.  Advances in the Development of Anti-Adhesive Biomaterials for Tendon Repair Treatment.

Authors:  Haiying Zhou; Hui Lu
Journal:  Tissue Eng Regen Med       Date:  2020-11-04       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.